Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Ruxolitinib in the Treatment of Cancer Cachexia

NCT04906746 is registered in ClinicalTrials.gov with Tu Dan as lead sponsor.

NCT NCT04906746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04906746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Ruxolitinib in the Treatment of Cancer Cachexia
Lead sponsor
Tu Dan
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 23, 2022
Completion date
September 30, 2026
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, stage iv non-small cell lung cancer